Viking Therapeutics (VKTX) Current Assets (2014 - 2026)
Viking Therapeutics' Current Assets was $517.56 million in Q2 2026, down 37.4% from $827.02 million a year earlier and down 14.9% from the prior quarter.
Viking Therapeutics (VKTX) Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Viking Therapeutics came in at $715.6 million, down 21.1% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 22.8% (FY2020 to FY2025).
- In earlier years, Current Assets was $907.22 million in FY2024 (+147.0%), $367.23 million in FY2023 (+119.8%), $167.04 million in FY2022 (-20.7%) and $210.53 million in FY2021 (-17.8%).
- The Q2 2026 figure marks the lowest quarterly Current Assets since Q4 2023.
- Compared with a year earlier, Current Assets has declined for six straight quarters, with growth averaging 20.0% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q1 2024 (growth of 546.5%); the worst was Q2 2026 (a decline of 37.4%).
- Per Business Quant data, VKTX's Current Assets in the three quarters before Q2 2026 was $608.21 million (Q1 2026), $715.6 million (Q4 2025) and $738.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Viking Therapeutics | 3.10 Bn | 576.60 Mn | - | 517.56 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 517.56 Mn |
| Mar 31, 2026 | 608.21 Mn |
| Dec 31, 2025 | 715.60 Mn |
| Sep 30, 2025 | 738.70 Mn |
| Jun 30, 2025 | 827.02 Mn |
| Mar 31, 2025 | 866.02 Mn |
| Dec 31, 2024 | 907.22 Mn |
| Sep 30, 2024 | 936.65 Mn |
| Jun 30, 2024 | 945.72 Mn |
| Mar 31, 2024 | 966.34 Mn |
| Dec 31, 2023 | 367.23 Mn |
| Sep 30, 2023 | 381.30 Mn |
| Jun 30, 2023 | 399.37 Mn |
| Mar 31, 2023 | 149.47 Mn |
| Dec 31, 2022 | 167.04 Mn |
| Sep 30, 2022 | 165.15 Mn |
| Jun 30, 2022 | 179.86 Mn |
| Mar 31, 2022 | 193.30 Mn |
| Dec 31, 2021 | 210.53 Mn |
| Sep 30, 2021 | 224.29 Mn |
Viking Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=VKTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();